A doctor who travels through two eras

October 1963, in the conference room of Bao'an County Pharmaceutical Factory.

Lin Sanqi sat in the main seat, with Shen Guoming, director of the industrial zone, Yuan Mingjie, director of Baoan Pharmaceutical Factory, Jia Xuezhen, director of Baoan County International Hospital (in preparation), and Shen Qiushui, director of Baoan County People's Hospital, sitting next to him.

In addition, professors from various universities who came to support Bao'an County, such as Professor Chai Guoli from Peking University, Professor Guo Wenhao and Professor Sun Yecong from China Pharmaceutical University, Professor Ren Rubing from Fudan University, and Professor Shi Longchang from Zhejiang University, were also present.

These people are currently the core team of medical technology in Bao'an County.

Lin Sanqi instructed his secretary, Bai Ruli, to distribute the documents, and then introduced them:

"The reason we've called everyone here for this closed-door meeting today is to summarize our past work and then tell you what kind of work we will be doing in the future."

Currently, our Bao'an County Pharmaceutical Factory only has one product: the anti-tuberculosis drug, etorizine fumigation tablets. The current sales volume is within my expectations. Could Factory Director Yuan please give us a brief introduction?

Factory Director Yuan chuckled and took over the conversation, saying:

"The popularity of ethylpyridaben smoked tablets has exceeded my expectations. We originally had 20 production lines in operation in the first phase, but that was far from enough to meet the needs of the international market."

Our second-phase factory is already in operation, adding an additional 30 production lines. Furthermore, we are already constructing our third-phase factory, with plans to add another 50 production lines.

Based on the current production situation, barring unforeseen circumstances, we can generate at least $50 billion in revenue this year, and according to Commissioner Lin's calculations, the gross profit should be around $35 billion.

As soon as this data was released, the meeting room became lively, with everyone looking on incredulously.

Even Shen Guoming remarked from the side:

"I never dreamed that such a potent medicine could be produced in a year. It truly shows me the benefits of technological advancement. But it's too expensive. Xiao Qi, are you really not going to pay?"

Lin Sanqi smiled wryly:

“How could we not pay? My bottom line is that the country pays $20 billion and our Lin family takes $1 million.”

Of the remaining funds, Bao'an County has reserved $5 million for factory construction, technological development, and worker wages, among other things. The remaining $9 million will be invested entirely in national healthcare.

Shen Guoming was a little surprised and asked in a low voice:

"According to the contract, your Lin family should have taken 10% of the revenue, which is $5 million. How come you only took $1 million?"

Lin Sanqi also lowered his voice to explain:

"Godfather, this is too much money. Even though I provided the technology and bought the production line, it wouldn't be too much for me to take half of it."

But money is a powerful motivator; the more I take, the more people will hate me.

If one day things get heated in China and we are held accountable, I will be the first one accused of exploiting socialism.

They don't care what contracts you signed before; if they want to mess with you, it's just a matter of a word.

So no matter how much, I'll take $1 million. No matter how profitable the Bao'an County pharmaceutical factory becomes in the future, I'll still take $1 million a year. That's enough for the Lin family to establish itself in Hong Kong. Money is a good thing, but being too greedy can lead to disaster.

Lin Sanqi said this without batting an eye, after all, there was still a $15 billion cost involved, which had also gone into his pocket.

However, the cost explanation is convincing; all the raw materials for the anti-tuberculosis drugs are supplied by Lin Sanqi, including the production line.

He wants to recoup some of his costs, which is perfectly understandable and can withstand scrutiny.

Shen Guoming nodded thoughtfully, and finally praised:

"Good. You didn't get carried away by the huge wealth and remained vigilant and self-reflective at all times. Excellent. Xiao Qi, with someone like you at the helm, your Lin family will definitely have a place in the country in the future."

Lin Sanqi instantly envisioned a scene in his mind: when he dies in the future, will he be able to drape the national flag over his head?

Lin Sanqi nominally took a symbolic amount of money from Bao'an County, but he had his own reasons for doing so.

(Is $1 million considered symbolic? Is there some misunderstanding about the meaning of symbolism?)

Bao'an County Industrial Park is, after all, located on mainland land. Although it is a joint public-private enterprise, the national trend in the coming years will inevitably make it belong to the state, and private individuals will have to withdraw. Decades later, when Bao'an County has become a "Special Economic Zone," it will be even less likely to belong to one family or clan, not even if one's surname is Ye.

Therefore, Lin Sanqi's voluntary retreat actually made things better. Of course, the country would not allow patriotic Hong Kong businessmen to suffer losses, and would provide sufficient compensation elsewhere.

The Lin family's monopoly on Hong Kong's sand and gravel business alone would be enough to make them one of Hong Kong's four major families in the near future.

One should not be too greedy; if one is too greedy, this wealth may not be one's own in the future.

Professor Chai Guoli also remarked at this moment:
"To be honest, I'm ashamed to say that after arriving in Bao'an County, I realized that I had wasted the last few decades of my life. All the pharmacology I had studied for most of my life was a complete mess. It also made me realize just how big the gap is between China and the world."

The annual production value of just one etoposide fumigation tablet can reach $50 billion! Wow, the combined production value of the entire pharmaceutical industry in our entire country doesn't even reach $50 billion, right?

Lin Sanqi then joked:
"In the most difficult time of 1961, our national treasury only had 50 million US dollars. Now, thanks to our efforts, the national treasury is much fuller and we can purchase more grain to alleviate the domestic food crisis."

But will everyone be satisfied with this?

Lin Sanqi glanced around at the excited crowd in the conference room and poured cold water on their enthusiasm:
"For a country as large as ours, several billion dollars is really just a drop in the bucket."

Among those present, including Director Yuan, several professors, and Dean Jia, all returned from studying abroad.

You all know how big the gap is between our country and developed countries in Europe and America.

The idea of ​​catching up with and surpassing Britain and the United States is currently just talk; to truly achieve this, the financial investment alone would be astronomical.

Of course, national development is not the responsibility of Bao'an County; that's the business of the higher-ups. We can't get carried away just because we have a little money.

But as members of the nation, especially when we have the strength and ability, we should do our part.

The information you all have contains three antibiotics: cefuroxime, azithromycin, and moxifloxacin.

These are three entirely new antibacterial drugs, and I have already applied for global patents through the Hong Kong Patent Office. To avoid unnecessary trouble, the patents remain in my personal possession.

If the patents are held by the Chinese government, it will be very difficult for drugs to enter Western markets, including Russia to the north.

Therefore, Lin Sanqi still plans to study anti-tuberculosis drugs, apply for patents under the name of Xiangjiang Company, then entrust the production in mainland China, and then sell them under the name of Xiangjiang Lingnan Pharmaceutical Company.

Of course, Lin Sanqi is planning to use a different sales strategy this time, but that's another story.

"These three antibiotics, I'm not exaggerating, could completely change the history of human diseases."

"Oh~~~"

The people in the conference room exclaimed in amazement again, but no one questioned it. Instead, they stared wide-eyed and listened intently, not wanting to miss this historic moment.

Seeing the foolish yet innocent looks in everyone's eyes, Lin Sanqi continued smugly:

"Since everyone here is a senior member of the medical community, an expert, or a professor, I'll introduce it in a slightly more technical way. First of all, cefuroxime is a cephalosporin antibiotic, which I guess most of you haven't heard of..."

Professor Chai Guoli then interrupted:

"Commissioner Lin, we are aware of cephalosporins. Scientists in the United States have already extracted cephalosporin C, which can be used to make an antibacterial drug. However, as far as I know, it is still in the research stage and no formal drug has been launched or put into clinical trials."

Lin Sanqi was a little surprised: "Wow, Professor Chai, you're quite something. You already know about this kind of research that's still in the laboratory stage back home."

It's important to understand that at that time, the domestic and international markets were quite closed off, with a complete information barrier. What good things were available abroad was almost entirely unknown to the domestic population.

Professor Chai was momentarily speechless upon hearing this, and explained:
“Mr. Bedford, a pharmacologist from the United States, was my classmate when I was studying abroad. We still correspond with each other. He is a cephalosporin researcher. The country also supports us in communicating more with our foreign counterparts to understand the situation.”

Lin Sanqi thought to himself, "They're supporting me now, but that might not be the case in the future. I should hurry back and burn all the letters."

"Yes, the United States has already conducted relevant research, but as you just mentioned, the United States has not yet officially launched any products, so we need to take the lead and seize the market."

Moreover, barring any unforeseen circumstances, the first cephalosporin drug launched by the United States is a first-generation drug, which focuses more on Gram-positive bacteria and has very high nephrotoxicity, while our cefuroxime does not have these side effects. (End of Chapter)